Company: UHS
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000950170-25-049925
Chunk: 19

Company: UNIVERSAL HEALTH SERVICES INC
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 19
---
 Stock beneficially owned by Vanguard Group is 7,042,246. Information is based on Amendment No. 11 to Schedule 13G dated February 13, 2024.

Notes (4)—(8) and (11)—(24) apply to the respective directors and executive officers as further indicated above.

| 9                                                    |
| Universal Health Services, Inc. 2025 Proxy Statement |

EQUITY COMPENSATION PLAN INFORMATION

The table below provides information, as of the end of December 31, 2024, concerning securities authorized for issuance under our equity compensation plans.

| Plan Category(1.)                                      |     | (a)               
 Number of         
 Securities to be  
 Issued Upon       
 Exercise of       
 Outstanding       
 Options, Warrants 
 and Rights(2.)    |           |     | (b)               
 Weighted          
 Average           
 Exercise Price    
 of  Outstanding   
 Options, Warrants 
 and Rights        |        |     | (c)                   
 Number of Securities  
 Remaining Available   
 for Future Issuance   
 under Equity          
 Compensation Plans    
 (excluding securities 
 reflected in          
 column (a))(3.)(4.)   |           |
|:-------------------------------------------------------|:----|:------------------|----------:|:----|:------------------|-------:|:----|:----------------------|----------:|
| Equity compensation plans approved by security holders |     |                   | 3,909,248 |     | $                 | 124.91 |     |                       | 9,747,878 |
| Total                                                  |     |                   | 3,909,248 |     | $                 | 124.91 |     |                       | 9,747,878 |

Shares of Class B Common Stock.

As of March 17, 2025, including options outstanding issued pursuant to our 2020 Omnibus Stock and Incentive Plan, there were 3,295,740 options outstanding with an approximate weighted-average exercise price of $133.58 and weighted average remaining term of approximately 2.1 years. All current outstanding stock options have terms that do not exceed five years. Additionally, as of March 17, 2025, there were 583,780 full-value restricted stock units outstanding and 156,968 performance-based restricted stock units outstanding. The restricted stock units do not have any voting rights.

As of December 31, 2024 and March 17, 2025, the Company’s 2020 Omnibus Stock and